Benzocaine 15 MG / menthol 3.6 MG Oral Lozenge [Cepacol Sore Throat Pain Relief] — RxCUI 1235477
RxNorm drug concept · Semantic branded drug
RxCUI 1235477
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1235477
Official nameBenzocaine 15 MG / menthol 3.6 MG Oral Lozenge [Cepacol Sore Throat Pain Relief]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asCepacol Sore Throat Pain Relief 15/3.6 Oral Lozenge; Cepacol Sore Throat 15 MG / 3.6 MG Oral Lozenge; Cepacol Sore Throat Pain Relief 15/3.6 (benzocaine / menthol) Oral Lozenge
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Menthol: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Menthol is found in a lot of over-the-counter topical products — creams, gels, patches, sprays, and powders. Depending on the product, it's used to temporarily ease minor muscle an...
- Start with clean, dry skin — free of lotions or creams — before applying the patch. Peel the backing off and press the sticky side firmly to the sore area. Most menthol patches sho...
- Yes, a mild burning or tingling feeling right after applying a menthol product is common and usually settles down within a few days of regular use. What's not normal is severe burn...
- Is that burning sensation after I apply it normal?
🕸️ Concept Web — How Benzocaine 15 MG / menthol 3.6 MG Oral Lozenge [... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Benzocaine 15 MG / menthol 3.6 MG Oral Lozenge [Cepacol Sore Throat Pain Relief]
RxCUI 1235477 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Benzocaine
1399IN -
Menthol
6750IN -
Benzocaine / menthol
466426MIN
-
Benzocaine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Cepacol Sore Throat Pain Relief
858658BN
-
Cepacol Sore Throat Pain Relief
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Benzocaine / menthol Oral Lozenge
374862SCDF -
Benzocaine / menthol Lozenge Product
1295280SCDG -
Benzocaine / menthol Oral Product
1152359SCDG -
Benzocaine / menthol Oral Lozenge [Cepacol Sore Throat Pain Relief]
1235465SBDF -
Cepacol Sore Throat Pain Relief Lozenge Product
1296480SBDG -
Cepacol Sore Throat Pain Relief Oral Product
1235466SBDG -
Oral Lozenge
316992DF -
Lozenge Product
1294702DFG - +1 more in this family
-
Benzocaine / menthol Oral Lozenge
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Benzocaine 15 MG / menthol 3.6 MG Oral Lozenge
824574SCD -
Benzocaine 15 MG
315469SCDC -
Menthol 3.6 MG
316238SCDC -
Benzocaine 15 MG / menthol 3.6 MG [Cepacol Sore Throat Pain Relief]
1235474SBDC
-
Benzocaine 15 MG / menthol 3.6 MG Oral Lozenge
Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Benzocaine 15 MG / menthol 3.6 MG Oral Lozenge
SCD · 824574 -
Benzocaine 15 MG
SCDC · 315469 -
Menthol 3.6 MG
SCDC · 316238 -
Benzocaine / menthol Oral Lozenge
SCDF · 374862 -
Benzocaine / menthol Lozenge Product
SCDG · 1295280 -
Benzocaine / menthol Oral Product
SCDG · 1152359
Brand-Name Concepts
-
Benzocaine 15 MG / menthol 3.6 MG [Cepacol Sore Throat Pain Relief]
SBDC · 1235474 -
Benzocaine / menthol Oral Lozenge [Cepacol Sore Throat Pain Relief]
SBDF · 1235465 -
Cepacol Sore Throat Pain Relief Lozenge Product
SBDG · 1296480 -
Cepacol Sore Throat Pain Relief Oral Product
SBDG · 1235466 -
Cepacol Sore Throat Pain Relief
BN · 858658
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 1235477 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 63824-0713-16 | 2 BLISTER PACK in 1 CARTON (63824-713-16) / 8 LOZENGE in 1... | Cepacol Extra Strength Sore Throat cherry | Reckitt Benckiser LLC | 2013-07-15 |
Observed labelers:
Reckitt Benckiser LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.